SCHEMBL3985349

SCHEMBL3985349

CC(C)Cn1c(-c2c(F)cccc2F)c(Cl)nc(NC=O)c1=O

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
MAPK14 Q16539 4/20 0.33
NPSR1 Q6W5P4 2/20 0.33
LMNA P02545 2/20 0.33
POLB P06746 1/20 0.33
GNRHR P30968 1/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
F2 P00734 4/20 0.33
F7 P08709 4/20 0.33
F3 P13726 4/20 0.33
P2RX3 P56373 1/20 0.32
THRB P10828 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986121 0.83 SMN1; SMN2 (0.39) ALDH1A1SMN1; SMN2MAPK14NPSR1LMNA
SCHEMBL4484784 0.80 SMN1; SMN2 (0.37) ALDH1A1SMN1; SMN2MAPK14NPSR1LMNA
SCHEMBL3913556 0.80 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2NPSR1LMNAPOLB
SCHEMBL4493753 0.77 CASR (0.38) ALDH1A1SMN1; SMN2MAPK14NPSR1LMNA
SCHEMBL3986025 0.75 HCRTR1 (0.37) ALDH1A1SMN1; SMN2MAPK14NPSR1POLB
SCHEMBL4483063 0.74 SYK (0.36) ALDH1A1SMN1; SMN2MAPK14NPSR1LMNA
SCHEMBL4418581 0.71 ADORA2B (0.32) MAPK14GNRHR
SCHEMBL3991579 0.71 SMN1; SMN2 (0.39) ALDH1A1SMN1; SMN2MAPK14NPSR1LMNA
SCHEMBL5319644 0.68 TDP1 (0.36) ALDH1A1SMN1; SMN2NPSR1LMNAGNRHR
SCHEMBL4877540 0.67 TSHR (0.35) ALDH1A1SMN1; SMN2NPSR1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors E.I. DUPONT DE NEMOURS AND COMPANY (US) 2009-07-23 US disclosed
EP-2034993-A2 PYRAZINONES AS CELLULAR PROLIFERATION INHIBITORS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-03-18 EP disclosed
US-20080194585-A1 Fungicidal Pyrazine Derivatives SHARPE PAULA LOUISE 2008-08-14 US disclosed
WO-2007149448-A2 PYRAZINONES AS CELLULAR PROLIFERATION INHIBITORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194585-A1 Fungicidal Pyrazine Derivatives CBR3, CBR1, NR0B1 ALDH1A1 2652/4885SMN1; SMN2 3995/4885MAPK14 2889/4885
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors MKI67, NR0B1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 ALDH1A1 1820/4885SMN1; SMN2 3158/4885MAPK14 1574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.